Efficient Early Drug Development for Ulcerative Colitis

Gastroenterology. 2016 May;150(5):1056-1060. doi: 10.1053/j.gastro.2016.03.013. Epub 2016 Mar 24.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / pharmacokinetics
  • Anti-Inflammatory Agents / therapeutic use*
  • Biopsy
  • Clinical Trials as Topic
  • Colitis, Ulcerative / diagnosis
  • Colitis, Ulcerative / drug therapy*
  • Colonoscopy
  • Diffusion of Innovation
  • Drug Discovery / methods*
  • Drug Discovery / organization & administration
  • Drug Evaluation, Preclinical
  • Efficiency, Organizational
  • Gastrointestinal Agents / adverse effects
  • Gastrointestinal Agents / pharmacokinetics
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Predictive Value of Tests
  • Remission Induction
  • Treatment Outcome
  • Workflow

Substances

  • Anti-Inflammatory Agents
  • Gastrointestinal Agents